by Manisha Kashyap, PhD
In a ground-breaking advancement that is poised to revolutionize the treatment of respiratory illnesses, researchers at Washington University School of Medicine in St. Louis have unveiled a remarkable discovery: sneezing and coughing, two reflexes that are often experienced together, are controlled by entirely separate neural pathways. This finding, published in the journal Cell on September 06, 2024, could lead to the development of highly targeted therapies that offer more effective relief with fewer side effects for millions of people worldwide. The open-access article is titled “Divergent Sensory Pathways of Sneezing and Coughing.”
The research, led by Dr. Qin Liu, has identified two distinct types of sensory neurons that govern these reflexes. The study reveals that MrgprC11+ neurons are responsible for triggering sneezes, while SST+ neurons are the key drivers behind coughing. This discovery fundamentally challenges the long-standing belief that sneezing and coughing share the same sensory pathways and opens entirely new avenues for medical research and treatment.
Impact of the Discovery
Sneezing and coughing are essential reflexes that protect the respiratory system by expelling irritants, pathogens, and allergens from the nose and lungs. However, when these reflexes become chronic or excessive, they can significantly impact quality of life, leading to discomfort, sleep disruption, and even physical strain. Current treatments often take a broad approach, attempting to suppress these symptoms using antihistamines, cough suppressants, and other medications. However, these treatments can have widespread side-effects because they do not target the specific neurons responsible for these reflexes.
With the discovery of these distinct neural pathways, there is now the potential to develop therapies that specifically target the neurons involved in sneezing or coughing, offering relief that is both more effective and safer. For example, a drug designed to inhibit MrgprC11+ neurons could stop a sneezing fit without affecting the body’s other functions, while a treatment targeting SST+ neurons could suppress a persistent cough without the sedative effects often associated with cough medicines.
How the Research Was Conducted
The research team’s success was made possible by the development of a new experimental model for studying coughing in mice. This innovative approach allowed the scientists to observe the reflexes in action and identify the specific neurons involved. By analyzing the behavior and responses of these neurons, the team was able to determine that while MrgprC11+ neurons are critical for the sneezing reflex, they play no role in coughing. Conversely, SST+ neurons, which are abundant in the trachea, were found to be the key players in the cough reflex.
This distinction not only advances our understanding of how these reflexes function but also provides a clear path for the creation of new treatments that can precisely target each reflex. The potential applications of this research are vast, extending far beyond the common cold and allergies to include more serious respiratory conditions.
Discussion
Sneezing and coughing are essential defense mechanisms of the respiratory system, crucial for expelling irritants, allergens, and pathogens. Traditionally, these reflexes were thought to be triggered by common sensory receptors. However, the findings in the study reveal distinct sensory neuron populations responsible for each reflex.
The study identified MrgprC11+ sensory neurons, which densely innervate the nasal mucosa, as the primary mediators of sneezing. In contrast, SST+ neurons, which innervate the lower airways, are critical for mediating coughing. SST+ neurons also selectively express receptors for inflammatory mediators like IL-31, making them particularly sensitive to airway inflammation—a key factor in conditions like asthma, long COVID, and COPD.
These distinct neuron populations may provide complementary sensory surveillance systems, enhancing the detection and clearance of harmful substances. While many viruses induce both sneezing and coughing, others, like early variants of SARS-CoV-2 and RSV, primarily trigger coughing, highlighting the importance of this dual mechanism.
Translating these findings from mice to humans is crucial, particularly the role of MrgprC11+ neurons in sneezing and SST+ neurons in coughing. Targeting these specific neuronal populations could lead to more effective and safer therapies for respiratory conditions, with ongoing research providing promising preclinical evidence.
In conclusion, this study not only clarifies the neural mechanisms behind sneezing and coughing but also identifies specific neuronal targets for developing novel therapeutic strategies for respiratory symptoms.
Potential Applications and Future Directions
The implications of this discovery are profound. In the future, patients suffering from conditions that cause chronic coughing, such as asthma, COPD, or post-viral syndromes like long COVID, could benefit from treatments that specifically inhibit the SST+ neurons responsible for the cough reflex. Similarly, individuals who experience frequent sneezing due to allergies or irritants could find relief in therapies that target MrgprC11+ neurons, without the drowsiness or other side effects associated with traditional antihistamines.
Moreover, this research opens the door to exploring how these neurons might be involved in other respiratory reflexes or conditions, potentially leading to new treatments for a range of respiratory disorders. The study has already attracted significant attention from the medical and scientific communities, with the potential to influence not only how we treat respiratory symptoms but also how we understand the brain’s control of reflexes more broadly.
Support and Future Research
This ground-breaking study was supported by major grants from the National Institutes of Health and the Pew Scholar Award, underscoring the importance of this research in the broader scientific community. As the researchers continue to explore the implications of their findings, they are also laying the groundwork for future studies that could translate these discoveries into real-world treatments.
About the Writer
Dr. Manisha Kashyap (Dr. MK)
BDS (Hons), MSc, PhD (Healthcare)
Manisha Kashyap earned a BS in Dentistry (Gold Medalist) and an MS in Clinical Research, and she is a driven PhD scholar in Health Policy and Management.
With a rich background as a Drug Safety Analyst for top-tier bio pharmaceutical companies, she blends clinical expertise with a passion for advancing healthcare accessibility and innovation through her writing career for the love of science and technology via MedKnow Research Writing Solutions.
Dr. Kashyap’s PhD thesis is on “Artificial Intelligence (AI) and Public Health: Harnessing the Power of AI for Enhanced Public Health Policy and Management.”